免疫原性
dna疫苗
结核分枝杆菌
脾脏
免疫系统
免疫学
肺结核
生物
病毒学
淋巴细胞
微生物学
医学
免疫
病理
作者
Yan Liang,Xiaoyan Zhang,Xuejuan Bai,Xiao Fan Li,Xiaomei Wang,Junxian Zhang,Yourong Yang,Jinying Song,Lan Wang,Xueqiong Wu
出处
期刊:BMC Immunology
[BioMed Central]
日期:2017-02-27
卷期号:18 (1): 11-11
被引量:15
标识
DOI:10.1186/s12865-017-0196-x
摘要
Tuberculosis (TB) is a major global public health problem. New treatment methods on TB are urgently demanded. In this study, Mycobacterium tuberculosis (MTB) rv2190c DNA vaccine was prepared and its immunogenicity and therapeutic effects were evaluated. Non-infected mice immunized with rv2190c DNA or ag85a DNA showed higher levels of interferon-gamma (IFN-γ) in stimulated spleen lymphocyte culture supernatants, and had more Th1 cells and an elevatory ratio of Th1/Th2 immune cells in whole blood, indicating that Th1-type immune response was predominant. Compared with the saline group, ag85a DNA group and rv2190c DNA group in the infected mice decreased the lung colony-forming units (CFUs) by 0.533 and 0.283 log 10 , and spleen CFUs by 0.425 and 0.321 log 10 respectively, and pathological lesion. The rv2190c DNA had some immunotherapeutic effect on TB.
科研通智能强力驱动
Strongly Powered by AbleSci AI